XGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Exagen (XGN) Earnings Date & Reports

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XGN is expected to report earnings to rise 7.85% to -21 cents per share on May 19

Q1'25

Est.

$-0.22

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.18

Q1'24

Beat

by $0.17

The last earnings report on March 11 showed earnings per share of -20 cents, beating the estimate of -31 cents. With 262.27K shares outstanding, the current market capitalization sits at 27.06M.

View a ticker or compare two or three

Compare

XGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XGN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

N/A

Address

1261 Liberty Way

Phone

+1 760 560-1501

Employees

179

Web

https://www.exagen.com